Thyroid carcinoma metastasis to the choroid responding to systemic 131I therapy [7]

I. Anteby; J. Pe'er; B. Uziely; Y. Krausz

doi:10.1016/S0002-9394(14)76178-1

Thyroid carcinoma metastasis to the choroid responding to systemic ¹³¹I therapy [7]

I. Anteby
, J. Pe'er^*
, B. Uziely
, Y. Krausz

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

20 Scopus citations

Original language	English
Pages (from-to)	461-462
Number of pages	2
Journal	American Journal of Ophthalmology
Volume	113
Issue number	4
DOIs	https://doi.org/10.1016/S0002-9394(14)76178-1
State	Published - 1992
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0002-9394(14)76178-1

Cite this

@article{75edaa4d4f90481da46a9c38b72e6933,

title = "Thyroid carcinoma metastasis to the choroid responding to systemic 131I therapy [7]",

author = "I. Anteby and J. Pe'er and B. Uziely and Y. Krausz",

year = "1992",

doi = "10.1016/S0002-9394(14)76178-1",

language = "אנגלית",

volume = "113",

pages = "461--462",

journal = "American Journal of Ophthalmology",

issn = "0002-9394",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Thyroid carcinoma metastasis to the choroid responding to systemic 131I therapy [7]

AU - Anteby, I.

AU - Pe'er, J.

AU - Uziely, B.

AU - Krausz, Y.

PY - 1992

Y1 - 1992

UR - https://www.scopus.com/pages/publications/0026572714

U2 - 10.1016/S0002-9394(14)76178-1

DO - 10.1016/S0002-9394(14)76178-1

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 1558128

AN - SCOPUS:0026572714

SN - 0002-9394

VL - 113

SP - 461

EP - 462

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

IS - 4

ER -

Thyroid carcinoma metastasis to the choroid responding to systemic 131I therapy [7]

UN SDGs

Access to Document

Other files and links

Cite this

Thyroid carcinoma metastasis to the choroid responding to systemic ¹³¹I therapy [7]